1. Aabo K, Pecdersen AG, Haid I, Dombemowky P (1982) High-dose medroxyprogesteronacetate in advanced chemotherapy-resistant ovarian carcinoma: a phase H study. Cancer Treat Rep 66: 407
2. Alberti W, Bamberger M, Schulz U (1984) Granulösazelltumoren. Ergebnisse der postoperativen Bestrahlung. Dtsch Med Wochenschr 109: 750–752
3. Alberts D, Green S, Hannigan E et al. (1989) Improved efficacy of carboplatin/cyclophosphamide versus cisplatin/cyclophosphamide: preliminary report of a phase HI, randomized trial in stages DI–IV, suboptimal ovarian cancer. Proc Am Soc Clin Oncol 8: 151
4. Annual Report (1982) Results of Treatment in Gynecological Cancer, vol 18. Radiumhemmet, Stockholm
5. Averette HE, Lovecchio JL, Townsend PA, Sevin BU, Girtanner RE (1983) Retroperitoneal lymphatic involvement by ovarian cancer. In: Grundmann E (ed) Carcinoma of the ovary. Fischer, Stuttgart (Cancer campaign, vl 7, p 101 )